InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the detailed record of transactions filed by Sharp Shalini, 董事. Director active across 4 companies, notably Mirati Therapeutics, Inc.. In total, 11 disclosures have been published. Activity tracked since 14 January 2022. The latest transaction was filed on 21 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Sharp Shalini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
18,980 股ShareXHKGHKEX:DA20260616E00304
18,980 股Ordinary SharesSEC:0001377202-26-000007:0
117 股ShareXHKGHKEX:DA20260515E00446
10,985 股0Ordinary SharesSEC:0001651308-25-000090:0
1,435 股0Common StockSEC:0000914475-25-000131:0
8,151 股0Ordinary SharesSEC:0001651308-24-000131:0
2,100 股0Common StockSEC:0000914475-24-000138:0
4,162 股Common StockSEC:0001140361-24-003537:0
6,808 股@ US$58.75100.0% 占其流量Common StockSEC:0001628280-24-000302:0
4,444 股0Common StockSEC:0001214659-23-001038:0
2,546 股0Common StockSEC:0001214659-22-000841:0
11 条申报中的 11 条
About Sharp Shalini
Sharp Shalini is Administrateur and has 11 filings in total. Among the recent filings available, the range runs from 2022-01-18 to 2026-06-16, with Attribution transactions, and the aggregated buy and sell amounts are 0 and 0.
